The Role of Inflammation and Immunity in Cardiovascular Disease: Molecular Mechanisms and Therapeutic Targets
MedComm · 2026-08 · 7 (8)
DOI: 10.1002/mco2.70878 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift MedComm, online erschienen am 19.07.2026. Verfasst von Jiaxiang Rong und 8 weiteren Autor:innen. Beteiligte Einrichtung: Shaanxi Province Key Laboratory of New Drugs and Chinese Medicine Foundation Research, School of Pharmacy Shaanxi University of Chinese Medicine Xi'a…. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 344 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Cardiovascular inflammation is increasingly recognized not merely as a secondary response to hemodynamic or metabolic injury, but as a determinant of disease initiation, progression, and remodeling. In the injured heart and vasculature, danger sensing, inflammatory priming, inflammasome activation, nucleic acid recognition, immunometabolic rewiring, immunothrombosis, adaptive immune remodeling, and defective resolution form interdependent circuits rather than isolated pathways. A key challenge is to understand how these circuits shift from adaptive clearance and repair to persistent immune activation, fibrosis, and functional decline. Here, we synthesize evidence on immune landscapes and core inflammatory networks in cardiovascular diseases, focusing on TLR–NF‐κB signaling, NLRP3 inflammasomes, cGAS–STING‐dependent cytosolic DNA sensing, alternative mitochondrial nucleic acid‐sensing platforms, and redox‐immunometabolic gating. We highlight mitochondrial quality control and mitochondria‐derived DAMPs, including mtDNA, mtROS, ATP, cardiolipin, and oxidized lipids, as an upstream interface linking metabolic stress to sterile immune activation. We further organize disease‐specific inflammatory patterns through a stage‐cell‐threshold perspective across ischemic injury, vascular and metabolic disease, and cardiomyopathic remodeling. Finally, we discuss network‐guided therapeutic strategies, translational limitations, biomarkers, endpoints, and safety considerations. This integrated perspective provides a conceptual basis for moving cardiovascular inflammatory therapy from broad suppression toward more precise network regulation.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Shaanxi Province Key Laboratory of New Drugs and Chinese Medicine Foundation Research, School of Pharmacy Shaanxi University of Chinese Medicine Xi'an Shaanxi China.
- Department of Pharmacy Affiliated Hospital of Shaanxi University of Chinese Medicine Xianyang China.
Zitieren
APA
Rong, J., Wang, Z., Lin, X., Lei, Z., Huang, Q., Liu, H., Luan, F., Zou, J., & Shi, Y. (2026). The Role of Inflammation and Immunity in Cardiovascular Disease: Molecular Mechanisms and Therapeutic Targets. MedComm, 7(8). https://doi.org/10.1002/mco2.70878
Vancouver
Rong J, Wang Z, Lin X, Lei Z, Huang Q, Liu H, et al. The Role of Inflammation and Immunity in Cardiovascular Disease: Molecular Mechanisms and Therapeutic Targets. MedComm. 2026;7(8). doi:10.1002/mco2.70878
BibTeX
@article{Rong2026,
author = {Rong, Jiaxiang and Wang, Zhen and Lin, Xiaoxiao and Lei, Ziwen and Huang, Qianqian and Liu, Hang and Luan, Fei and Zou, Junbo and Shi, Yajun},
title = {The Role of Inflammation and Immunity in Cardiovascular Disease: Molecular Mechanisms and Therapeutic Targets},
journal = {MedComm},
year = {2026},
volume = {7},
number = {8},
doi = {10.1002/mco2.70878}
}
EUVIMED